🇰🇷 South Korea Country × Condition
dyslipidemias Clinical Trials in South Korea
Active clinical trials for dyslipidemias with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 4 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇰🇷 South Korea
Active Trials in South Korea (2)
NCT06322056
Recruiting
Exploring Approaches With Lower Targets of Blood Pressure and Lipid for Improving Renal Outcome in Advanced Chronic Kidney Disease
Enrollment
642 pts
Country
🇰🇷 South Korea
Yonsei University
View Trial → NCT06186037 Phase 4
Recruiting
Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention
Enrollment
6,356 pts
Country
🇰🇷 South Korea
Saint Vincent's Hospital, Korea
View Trial → Frequently Asked Questions
How many dyslipidemias clinical trials are active in South Korea?
There are currently 2 active clinical trials for dyslipidemias with sites in South Korea, of which 2 are actively recruiting patients.
How can I join a dyslipidemias clinical trial in South Korea?
To join a dyslipidemias clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are dyslipidemias trials in South Korea?
Active dyslipidemias trials in South Korea span Phase 4. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.